1 / 10

Global Cardiac POC Market Size, Analysis 2014-2018

About Cardiac POC Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides. The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients. TechNavio's analysts forecast the Global Cardiac POC market will grow at a CAGR of 14.40 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT. Get full access of the report at: http://www.researchbeam.com/global-cardiac-poc-2014-2018-market

Télécharger la présentation

Global Cardiac POC Market Size, Analysis 2014-2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Cardiac POC Market 2014-2018 Publish By: Technovia Toll Free: +1 (855) 711-1555 Email: sales@researchbeam.com

  2. Report Overview About Cardiac POC Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenaseisoenzymes and brain natriuretic peptides. The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients. TechNavio's analysts forecast the Global Cardiac POC market will grow at a CAGR of 14.40 percent over the period 2013-2018.

  3. Report Overview Covered in this Report This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT. The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC market. In addition, it discusses the major drivers that influence the growth of the Global Cardiac POC market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market. TechNavio's report, the Global Cardiac POC Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cardiac POC market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Get full access of the report at: http://www.researchbeam.com/global-cardiac-poc-2014-2018-market

  4. Report Overview Key Regions • Americas • EMEA • APAC Key Vendors • Alere Inc. • Abbott Laboratories • Roche Diagnostics Other Prominent Vendors • Beckman Coulter, Inc. • BG Medicine Inc. • Boston Scientific Corp • Medtronic Inc. • Randox Laboratories Ltd. Key Market Driver • Increasing Incidence of Cardiac Disorders. • For a full, detailed list, view our report.

  5. Report Overview Key Market Challenge • Lack of Specific Actions in Detecting the Presence of Cardiovascular Diseases. • For a full, detailed list, view our report. Key Market Trend • Introduction of Enhanced Products. • For a full, detailed list, view our report. Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be- • What are the key market trends- • What is driving this market- • What are the challenges to market growth- • Who are the key vendors in this market space- • What are the market opportunities and threats faced by the key vendors- • What are the strengths and weaknesses of the key vendors-

  6. Table Of Content 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape

  7. Table Of Content 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Market Segmentation by Type of Tests 08. Global Cardiac Troponin Test Market 08.1 Market Overview 08.2 Market Size and Forecast 09. Global Cardiac BNP Test Market 09.1 Market Overview 09.2 Market Size and Forecast

  8. List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Global Cardiac POC Market for 2013-2018 in (US$ million) Exhibit 3: Global Cardiac POC Market Segmentation by Type of Test Exhibit 4: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018 in (US$ million) Exhibit 5: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018 Exhibit 6: Global Cardiac Troponin Test Market 2013-2018 (US$ million) Exhibit 7: Global Cardiac BNP Test Market 2013-2018 (US$ million) Exhibit 8: Global Cardiac POC Market by Geographical Segmentation 2013 Exhibit 9: Global Cardiac POC Market Vendor Share Analysis 2013 Exhibit 10: Abbott Laboratories: Business Segmentation by Revenue 2012

  9. List of Exhibits Exhibit 11: Abbott Laboratories: Business Segmentation by Revenue 2012 and 2013 (US$ million) Exhibit 12: Abbott Laboratories: Sales by Geography 2012 Exhibit 13: Business Segmentation of Alere Exhibit 14: Alere Business Segmentation by Revenue 2013 Exhibit 15: Alere Geographical Segmentation by Revenue 2013 Exhibit 16: Roche Diagnostics: Business Segmentation by Revenue 2013 Exhibit 17: Roche Diagnostics: Geographical Segmentation by Revenue 2013 To make an enquiry before purchasing the report, visit at: http://www.researchbeam.com/global-cardiac-poc-2014-2018-market/purchase-enquiry

  10. Contact Us Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Web: www.researchbeam.com Email: sales@researchbeam.com Deep Joshi 5320 SW Macadam Avenue, Suite 100, Portland, OR 97239 United States

More Related